BioSpace News Archive

Medable Inc., the leading cloud platform for patient-centered drug development, announced the addition of four new members to its Patient Advisory Council.

Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Selecta’s Chief Executive Officer, Carsten Brunn, Ph.D., will provide a corporate update and participate in one-on-one investor meetings at the SVB Leerink 10 th

Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a live panel discussion titled, The Evolution of Birth Control: Considerations from Product Development to End-User Adoption from Leading Innovators, at 12:30 p.m. EST / 9:30 a.m. PST on Tuesday, February 23, 2021

Microbix Biosystems Inc., a life sciences innovator and exporter, announces an agreement with Oneworld Accuracy Inc. to distribute Microbix’s Quality Assessment Products on a non-exclusive basis across the continent of Africa, in Canada, and in the United States.

Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy to treat severely calcified cardiovascular disease, announced that the company’s sonic pressure wave therapy received Pre-Market Approval for severely calcified coronary artery disease from the U.S. Food and Drug Administration.

Kraig Biocraft Laboratories, Inc., the biotechnology company focused on the development and commercialization of spider silk, announces that the Company has filed a patent application protecting its most advanced knock-in knock-out gene editing technologies for the creation of nearly pure spider silk.

Bio-Techne Corporation announced that Chuck Kummeth, President and Chief Executive Officer, will present at Citi’s 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference on Thursday, February 25, 2021 at 9:50 a.m. EST.

GW Pharmaceuticals plc, a world leader in the science, development, and commercialization of cannabinoid prescription medicines, announced financial results and operating progress for the fourth quarter and full-year ended December 31, 2020.

SMART Medical has now commenced clinical collaboration with NYU Langone Health introducing its newly FDA-cleared G-EYE® 760 Colonoscope series, based on FUJIFILM Corporation’s 510 cleared 760 colonoscopes and operating with Fujifilm’s state-of-the-art ELUXEO imaging system

Windtree Therapeutics, Inc., a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, announced that the United States Patent and Trademark Office has issued U.S. Patent No. 10,874,818, covering features of the aerosol delivery system for the Company’s AEROSURF® drug delivery device.